Journal for ImmunoTherapy of Cancer (Nov 2023)
1397 CDR404, an antibody-based bispecific & bivalent T-cell engager targeted against MAGE-A4, for Squamous Non-Small Cell Lung Cancer (SQ-NSCLC)
- Elizabeth Ross,
- Swethajit Biswas,
- Gilberto Lopes,
- Melissa Vrohlings,
- Stephanie Jungmichel,
- Ivana Tosevski,
- Alessio Vantellini,
- Philip Knobel,
- Nadia Sanchez,
- Marian Van Kerckhoven,
- Giorgia Giacomazzi,
- Maria Liivrand,
- Reija Hieta,
- Nicholas Dupuis,
- Dieter Rondas,
- Pamela Swatkowski,
- Daniel Lenherr-Frey,
- Leonardo Borras
Affiliations
- Elizabeth Ross
- 2CellCarta, Antwerp, Belgium
- Swethajit Biswas
- 1CDR-Life, Zurich, Switzerland
- Gilberto Lopes
- 6University of Miami, Miller School of Medicine, Miami, FL, USA
- Melissa Vrohlings
- 1CDR-Life, Zurich, Switzerland
- Stephanie Jungmichel
- 1CDR-Life, Zurich, Switzerland
- Ivana Tosevski
- 1CDR-Life, Zurich, Switzerland
- Alessio Vantellini
- 1CDR-Life, Zurich, Switzerland
- Philip Knobel
- 1CDR-Life, Zurich, Switzerland
- Nadia Sanchez
- 1CDR-Life, Zurich, Switzerland
- Marian Van Kerckhoven
- 2CellCarta, Antwerp, Belgium
- Giorgia Giacomazzi
- 2CellCarta, Antwerp, Belgium
- Maria Liivrand
- 3Genevia Technologies, Tampere, Tampere, Finland
- Reija Hieta
- 3Genevia Technologies, Tampere, Tampere, Finland
- Nicholas Dupuis
- CelCarta, Montreal, QC, Canada
- Dieter Rondas
- 2CellCarta, Antwerp, Belgium
- Pamela Swatkowski
- 5CellCarta, Boulder, CO, USA
- Daniel Lenherr-Frey
- 1CDR-Life, Zurich, Switzerland
- Leonardo Borras
- 1CDR-Life, Zurich, Switzerland
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.1397
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.
